Johnson & Johnson JNJ
NYSE JNJ
$270.30 +2.93 (+1.09%)
As of: Aug 21, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Other Working Capital Changes (2009 - 2026)

Johnson & Johnson (JNJ) posted Other Working Capital Changes of -$950.0 million for Q2 2026, down 172.21% sequentially from -$349.0 million in Q1 2026, and down 119.48% YoY from $4.9 billion in Q2 2025.

Johnson & Johnson (JNJ) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Other Working Capital Changes for 18 years, with the latest figure at -$950.0 million in Q2 2026.

  • Quarterly Other Working Capital Changes fell 119.48% year-over-year to -$950.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.3 billion (down 116.15% YoY) and the FY2025 annual result came in at $6.2 billion, up 459.17% from the prior year.
  • Other Working Capital Changes declined to -$950.0 million in Q2 2026 per JNJ's latest filing, from -$349.0 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $4.9 billion in Q2 2025 and troughed at -$3.2 billion in Q1 2024.
  • A 5-year average of $439.4 million and a median of $225.5 million in 2023 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 1153.15% in 2024, down 449.62% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$995.0 million in 2022, then surged by 312.46% to $2.1 billion in 2023, then plunged by 136.33% to -$768.0 million in 2024, then tumbled by 93.49% to -$1.5 billion in 2025, then surged by 36.07% to -$950.0 million in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$950.0 million, -$349.0 million, and -$1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 -950.00 Mn
Jun 28, 2026 -950.00 Mn
Jun 28, 2026 -950.00 Mn
Mar 29, 2026 -349.00 Mn
Mar 29, 2026 -349.00 Mn
Mar 29, 2026 -349.00 Mn
Dec 28, 2025 -1.49 Bn
Dec 28, 2025 -1.49 Bn
Dec 28, 2025 -1.49 Bn
Sep 28, 2025 1.46 Bn
Sep 28, 2025 1.46 Bn
Sep 28, 2025 1.46 Bn
Jun 29, 2025 4.88 Bn
Jun 29, 2025 4.88 Bn
Jun 29, 2025 4.88 Bn
Mar 30, 2025 1.32 Bn
Mar 30, 2025 1.32 Bn
Mar 30, 2025 1.32 Bn
Dec 29, 2024 -768.00 Mn
Dec 29, 2024 -768.00 Mn